Senior Front-End Engineer, Pendulum Therapeutics
E-Commerce, Data and Systems
$150.8-167.6k
+ Equity
Reinventing personal health naturally through the microbiome
Job no longer available
Reinventing personal health naturally through the microbiome
101-200 employees
Job no longer available
$150.8-167.6k
+ Equity
101-200 employees
Company mission
To bridge nature and medicine.
Role
Who you are
- Bachelor’s degree in Computer Science, a related field, or equivalent work experience
- At least 5 years of experience in responsive front-end web development
- Strong proficiency in Typescript and React
- Experience developing for the Shopify platform (e.g. Liquid, Hydrogen)
- Ability to work in a fast paced, dynamic environment where adaptability is imperative
- Excellent problem-solving skills and attention to detail
- Strong communication skills and ability to work collaboratively in a team environment
What the job involves
- We are currently seeking an experienced Senior Front-End Engineer who will play a crucial role in developing our e-commerce platform
- This role requires extensive expertise in front-end web development to contribute to Pendulum’s commercial growth
- As a Senior Front-End Engineer, your main objective will be to maintain and enhance our e-commerce platform
- Collaborate with key stakeholders in Marketing & E-Commerce to develop new features and launch new product initiatives on our consumer site
- Work with the broader Data & Systems team to ensure ongoing stability, performance, and maintenance of our consumer site
- Implement responsive web designs to enhance user experience
- Optimize the e-commerce platform for maximum speed and scalability
- Integrate with backend services and third-party APIs
- Participate in code reviews and provide constructive feedback
- Stay up-to-date with emerging trends and technologies in front-end development
Our take
Pendulum Therapeutics developed its product by analysing the genetic material of microbes in the human body. Its debut product, Pendulum Glucose Control, is a medical probiotic, the first of its type to be clinically proven to be effective at lowering blood sugar spikes in people with type 2 diabetes. Classified as a medical food, it bridges the gap between medication that can cause side effects and generic probiotic products that have no scientific backup with regard to efficacy.
Pendulum Glucose Control has been greatly in demand, and so with a $54M investment, manufacturing has scaled up. Other products from Pendulum include supplements for gut health and metabolism optimisation supplements, the latter also becoming a key product from the team.
In 2023, Pendulum increased its already thriving publicity with the appointment of actor Halle Berry as its CCO, hinting at a scaling up of its operations in line with its media visibility. Its 2024 breakthrough product has been its GLP-1 Probiotic drink, a first-of-its-kind drink to control metabolism.
Kirsty
Company Specialist at Welcome to the Jungle
Insights
-1% employee growth in 12 months
Company
Company benefits
- 401k with company matching
- Competitive salary and equity packages
- Health, dental, vision, and life insurance
- Flexible schedules and unlimited vacation policy
- Commuter benefits
- Cell phone stipend
- Collaborative team environment
- Casual culture (66% of founders usually wear hoodies)
- Small on-site gym
- Strong emphasis on work/life balance: we believe it, we encourage it, we live it
- Walking distance to Bart & Muni
Company HQ
Dogpatch, San Francisco, CA
Leadership
John Eid
(Co-Founder & CSO)They took a Ph.D. at The University of Illinois before spending 8 years at Pacific Biosciences. They left this Principal Scientist role in September 2013 to co-found Pendulum Therapeutics, serving since as Chief Scientific Officer.
Colleen Cutcliffe
(Co-Founder & CEO)Having studied for a Ph.D. at John Hopkins University, they worked as a Hospital Project Manager for 3 years prior to joining Elan Pharmaceuticals as a Scientist. They spent 4 years at Pacific Biosciences with John before co-founding Pendulum Therapeutics in 2013.
Share this job
View 1 more job at Pendulum Therapeutics